VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 397 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,104,021 | +30.7% | 527,007 | +10.0% | 7.23% | +10.2% |
| Q3 2022 | $11,554,000 | -45.1% | 479,012 | -37.7% | 6.56% | -43.3% |
| Q2 2022 | $21,043,000 | -28.3% | 768,567 | +0.4% | 11.57% | -11.5% |
| Q1 2022 | $29,361,000 | +28.6% | 765,613 | +7.4% | 13.08% | +11.7% |
| Q4 2021 | $22,827,000 | +15.6% | 712,669 | +6.3% | 11.71% | -4.3% |
| Q3 2021 | $19,753,000 | -13.4% | 670,275 | -0.2% | 12.24% | -13.7% |
| Q2 2021 | $22,816,000 | -2.0% | 671,454 | -6.2% | 14.18% | -7.2% |
| Q1 2021 | $23,270,000 | -9.2% | 716,007 | +0.6% | 15.28% | +0.1% |
| Q4 2020 | $25,631,000 | -11.0% | 711,589 | -3.2% | 15.27% | -15.0% |
| Q3 2020 | $28,801,000 | +36.3% | 735,464 | +27.7% | 17.95% | +11.0% |
| Q2 2020 | $21,133,000 | +61.0% | 576,149 | +1.1% | 16.17% | +31.9% |
| Q1 2020 | $13,126,000 | -18.7% | 569,667 | +3.4% | 12.26% | +46.1% |
| Q4 2019 | $16,136,000 | +38.7% | 551,069 | +26.5% | 8.39% | +7.2% |
| Q3 2019 | $11,635,000 | +16.8% | 435,620 | +11.8% | 7.83% | -13.4% |
| Q2 2019 | $9,960,000 | +767.6% | 389,679 | +657.3% | 9.04% | +896.9% |
| Q2 2018 | $1,148,000 | – | 51,455 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |